// Interactive Response Technology (IRT) integration // How to improve site experience through IRT and eCOA integration? Benefit from our open eCOA platform to optimize your clinical trial data flow: https://bit.ly/3W4Jxga #kayentis #eCOA #clinicaltrials #IRT #IntegrationWhenItMakesSense
Kayentis
Fabrication de produits pharmaceutiques
Meylan, Auvergne-Rhone-Alpes 6 778 abonnés
Simplify your clinical trial experience
À propos
Kayentis, a global provider of eCOA (electronic Clinical Outcome Assessment) and Decentralized Clinical Trial solutions (DCTs), helps pharma, biotech and CROs bring simplicity, efficiency and quality to the collection of clinical trial data from both patients and sites. Since 2005, Kayentis has been active in clinical development, with a strong specialization in eCOA solutions for phases I-IV across a broad range of therapeutic areas. Over the years, it has developed a full range of services and has enlarged its portfolio beyond eCOA solutions to support the new normal of decentralized and hybrid trials. The company has conducted digital data collection for over 300 clinical trials in 90 countries (100,000 patients), employing 120 languages. It has offices in the US (Boston), France (Grenoble) and Japan (Tokyo), and currently employs 185 staff.
- Site web
-
https://kayentis.com/resources
Lien externe pour Kayentis
- Secteur
- Fabrication de produits pharmaceutiques
- Taille de l’entreprise
- 51-200 employés
- Siège social
- Meylan, Auvergne-Rhone-Alpes
- Type
- Société civile/Société commerciale/Autres types de sociétés
- Fondée en
- 2003
- Domaines
- eCOA solutions, Patient engagement, Electronic Clinical Outcome Assessments, Clinical Trials, ePRO, ClinRO, ObsRO, PerfO, eDiary, PRO, DCT solutions, BYOD et Televisit
Lieux
-
Principal
19 bis, Chemin du Vieux Chêne
38240 Meylan, Auvergne-Rhone-Alpes, FR
-
186 South St
Suite 600
02111 Boston, Massachusetts, US
Employés chez Kayentis
Nouvelles
-
We're #hiring a new Stagiaire spécialiste contenu graphique et vidéo (H/F) in Meylan, Auvergne-Rhône-Alpes. Apply today or share this post with your network.
-
// One week before the webinar on BYOD implementation strategies! // Join the Critical Path Institute's eCOA Consortium panel of experts, including Chris Barden, on July 18! This webinar will explore the pivotal considerations for employing Bring Your Own Device (BYOD) strategies in the collection of electronic clinical outcome assessment data within clinical trials. #kayentis #eCOA #clinicaltrials #BYOD
JOIN US Thursday, July 18, for an in-depth look at the key considerations around the use of Bring Your Own Device (BYOD) approaches to electronic clinical outcome assessment data collection in clinical trials, developed and presented by members of the BYOD Project Team as part of the eCOA Consortium and PRO Consortium’s eCOA: Getting Better Together Initiative. Register now: https://lnkd.in/enx2u4Xb Karl McEvoy Kelly Dumais Chris Barden Heather Romero Scottie Kern eCOA members, include: ActiGraph Evinova Clario ICON plc Inspired Health IQVIA Kayentis Koneksa Mapi Research Trust Medable, Inc Medidata Solutions Medrio ObvioHealth Parexel Red Nucleus RWS Group Signant Health Suvoda TransPerfect Life Sciences uMotif WCG YPrime #CPath #eCOA #DHT #ACT #eCOAC #globalhealth #collaboration #drugdevelopment #datasharing #clinicaltrials
-
-
// Challenge your eCOA vendor // ✨ Experience client satisfaction with us - where terms like responsiveness, reliability, professionalism, friendliness, and excellence define the essence of what we deliver. ✅ These qualities ensure consistency and underscore the positive experiences of our clients, enabling us to showcase a recommendation rate of over 90% for the past three years. #kayentis #eCOA #clinicaltrials #clientsatisfaction
-
// Rare disease clinical research // 👨⚖️ What is the specific position of regulatory agencies in rare diseases clinical trials? 🙌 How does engaging with patient organizations improve rare disease drug development? ✅ How important do Patient Reported Outcomes need to become to improve the success of rare disease clinical trials? 👉 Read the full article: https://bit.ly/3KFLMRu #kayentis #eCOA #clinicaltrials #raredisease
Rare disease clinical research: it is time to tackle what matters most to patients - Kayentis
https://kayentis.com
-
// BYOD – Ensuring adoption by sites and patients for your clinical trial // Discover everything your sites need to know to feel comfortable when their patients use the Clin’form App, Kayentis BYOD solution, to collect eCOA data! #kayentis #eCOA #clinicaltrials #BYOD
-
// Join the #KayentisTeam! // 🙌 At Kayentis, we value each individual and we form a community that goes beyond the sum of individuals. Our company’s growth is built on the competencies, experience, and values of its employees, including both hard and soft skills and irrespective of gender. 💼 Check our job offers: https://bit.ly/4covRmV #kayentis #clinicalstudies #eCOA #employeesatisfaction #HR
-
// Why you should implement a BYOD strategy for your eCOA trial // Improve your clinical trial efficiency and offer more choice to patients by implementing a BYOD strategy for your eCOA trial! #kayentis #eCOA #clinicalstrials #patientengagement
-
// Clinical research in rare diseases // Partnering with patients and ensuring that their voices are heard are among the first and foremost steps to improve the success rate of clinical trials in rare diseases: https://bit.ly/4eJn7ta #kayentis #eCOA #clinicaltrials #raredisease
Partnering with patients - Kayentis
https://pharmatimes.com
-
// Kayentis and ClinOne combined solution // Improve your eCOA data collection and clinical trial efficiency thanks to Kayentis and ClinOne combined solution! #kayentis #clinicaltrials #eCOA #DCT #IntegrationWhenItMakesSense
Pages similaires
Parcourir les offres d’emploi
Financement
Dernier round
Série inconnue2 384 547,00 $US